Since viruses and abnormal cells are electrically charged, we postulated opposite charges electrostatic-mopping as treatment-mechanism for viral diseases and tumors. Molecules of Aluminum-magnesium silicate (AMS), WHO- approved medicine/adjuvant, consist of Nano- particles with positive and negative ends. Their ultra-small size (0.96 nm) enables them get to all organs to mop viruses and abnormal cells. As an adjuvant and a silicate, AMS improves antimicrobials` efficacies and enhances patients` immunity. Mopping HIV and HIV-infected cells, clearing secondary infections and enhancing immunity cure viral diseases and tumors. AMS-deposits may not exist in some countries and the medicine is un-absorbable. So, Aluminum silicate and Magnesium silicate (approved medicines) were used to formulate AMS-brand, named Medicinal synthetic AMS {MSAMS: Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}. Dextrose monohydrate was incor- porated to transport it into blood-circulation. That MSAMS-treated patient remained HIV- negative, 10 months post treatment has already been reported. Another patient monitored for 34 months also remained negative.
Since viruses and abnormal cells are electrically charged, we postulated opposite charges electrostatic-mopping as treatment-mechanism for viral diseases and tumors. Molecules of Aluminum-magnesium silicate (AMS), WHO- approved medicine/adjuvant, consist of Nano- particles with positive and negative ends. Their ultra-small size (0.96 nm) enables them get to all organs to mop viruses and abnormal cells. As an adjuvant and a silicate, AMS improves antimicrobials` efficacies and enhances patients` immunity. Mopping HIV and HIV-infected cells, clearing secondary infections and enhancing immunity cure viral diseases and tumors. AMS-deposits may not exist in some countries and the medicine is un-absorbable. So, Aluminum silicate and Magnesium silicate (approved medicines) were used to formulate AMS-brand, named Medicinal synthetic AMS {MSAMS: Al4 (SiO4)3 + 3Mg2SiO4 → 2Al2Mg3 (SiO4)3}. Dextrose monohydrate was incor- porated to transport it into blood-circulation. That MSAMS-treated patient remained HIV- negative, 10 months post treatment has already been reported. Another patient monitored for 34 months also remained negative.